Robert Hawkins
Director/Board Member at BIVICTRIX THERAPEUTICS PLC
Net worth: 32 945 $ as of 30/05/2024
Robert Hawkins active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BIVICTRIX THERAPEUTICS PLC | Director/Board Member | 21/09/2021 | - |
| Independent Dir/Board Member | 21/09/2021 | - |
Career history of Robert Hawkins
Former positions of Robert Hawkins
| Companies | Position | Start | End |
|---|---|---|---|
| INSTIL BIO, INC. | Chief Tech/Sci/R&D Officer | 10/11/2022 | 30/04/2024 |
| INSTIL BIO, INC. | Director/Board Member | 31/01/2019 | 30/06/2020 |
| Instil Bio (UK) Ltd. | Chief Executive Officer | - | 31/12/2019 |
| Founder | - | 31/12/2019 | |
| The University of Manchester | Corporate Officer/Principal | - | - |
| MOTIF BIO PLC | Director/Board Member | 13/06/2021 | - |
Training of Robert Hawkins
| University of Cambridge | Doctorate Degree |
| University College London | Doctorate Degree |
Statistics
International
| United Kingdom | 7 |
| United States | 2 |
Operational
| Director/Board Member | 3 |
| Doctorate Degree | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BIVICTRIX THERAPEUTICS PLC | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
| Instil Bio (UK) Ltd. |
- Stock Market
- Insiders
- Robert Hawkins
- Experience
